search
Back to results

Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity

Primary Purpose

Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome of Shoulder and Allied Disorders

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Rotium nanoscaffold
Control arm rotator cuff repair
Sponsored by
Joshua Szabo, MD
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Rotator Cuff Tears

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • -symptomatic supraspinatus or supraspinatus and infraspinatus tear that can be repaired to the greater tuberosity in an anatomical manner using a dual layer repair technique.
  • also included will be patients that have concomitant pathology addressed at time of surgery, specifically pathologies of the biceps tendon (tenodesis or tenotomy), arthrosis of the acromioclavicular joint (distal clavicle resection), or labral tearing (debridement or repair)
  • included age range of subjects will be from 18-80 years old

Exclusion Criteria:

  • diabetes, cancer or medical states that may impair healing, such as organ transplantation or systemic inflammatory process treated with immune modulating drugs (chemotherapy, immunosuppression drugs)
  • prior surgery to the ipsilateral rotator cuff tendon
  • need of soft tissue releases to accomplish an anatomic repair, partial repairs and/or concomitant subscapularis repair
  • significant glenohumeral arthritis
  • active or ongoing infection
  • pregnancy

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Rotium patch recipient

    Control

    Arm Description

    Subjects with Rotium nano scaffold patch included in rotator cuff repair construct

    Subjects undergoing non-patch augmented rotator cuff repair

    Outcomes

    Primary Outcome Measures

    Rotator cuff integrity baseline/preoperative
    ultrasound assessment of rotator cuff
    Rotator cuff repair integrity @ 2 weeks
    ultrasound assessment of rotator cuff
    Rotator cuff repair integrity @ 4 weeks
    ultrasound assessment of rotator cuff
    Rotator cuff repair integrity @ 6 weeks
    ultrasound assessment of rotator cuff
    Rotator cuff repair integrity @ 3 months
    ultrasound assessment of rotator cuff
    Rotator cuff repair integrity @ 6 months
    ultrasound assessment of rotator cuff
    Rotator cuff repair integrity @ 12 months
    ultrasound assessment of rotator cuff
    Postoperative rotator cuff vascularity during healing
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
    Postoperative rotator cuff vascularity during healing
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
    Postoperative rotator cuff vascularity during healing
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
    Postoperative rotator cuff vascularity during healing
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
    Postoperative rotator cuff vascularity during healing
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
    Postoperative rotator cuff vascularity during healing
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)

    Secondary Outcome Measures

    University California Los Angeles Shoulder score
    Outcome score
    Rowe score
    Outcome score
    Constant score
    Outcome score
    American shoulder and elbow surgeons score
    Outcome score
    SANE score
    Outcome score

    Full Information

    First Posted
    April 17, 2020
    Last Updated
    October 16, 2022
    Sponsor
    Joshua Szabo, MD
    Collaborators
    Atreon Orthopedics
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04361266
    Brief Title
    Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity
    Official Title
    Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2022
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    withdrawn
    Study Start Date
    August 1, 2022 (Anticipated)
    Primary Completion Date
    August 1, 2023 (Anticipated)
    Study Completion Date
    November 1, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    Joshua Szabo, MD
    Collaborators
    Atreon Orthopedics

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose is to assess Rotium, a novel nanoscaffold, impact on healing of a repaired rotator cuff and compare to a repair without Rotium. Animal (sheep) models have shown both quicker and more organized healing when Rotium is used, but there are no studies to confirm these outcomes translate to human population. Hypothesis: Rotium rotator cuff repairs will heal both quicker and better than traditional rotator cuff repair techniques.
    Detailed Description
    Patients indicated for rotator cuff repair surgery will be offered participation within the study and consented accordingly. A copy of the consent will be provided to the participant. A preoperative ultrasonographic assessment will occur by Dr. Onishi. A randomization process by computer program will determine patients who have Rotium augmented repairs, or not. The patients will not be blinded. The surgery will be carried out by a single surgeon making all aspects uniform, except if there is or is not a Rotium patch. The Rotium patch will be implanted in accordance to standards of handling sterile implants and placed in a manner that is consistent to its FDA approval. The patch will be furnished by the institution where the surgery is being performed. Digital photography will document pertinent arthroscopic operative findings per standard of care. Participant assessment will commence preoperatively in an outpatient clinic then continue in postoperative period, occurring at 2, 4, 6 weeks and 3, 6 and 12 month intervals. During each visit, the participants will be assessed by two clinicians: the principal investigator and a blinded ultrasonographer. Preoperative assessment will include obtaining baseline patient reported outcomes (UCLA, Rowe, Constant, American Shoulder and Elbow Surgeons (ASES) score and SANE (Single Alpha Numeric Evaluation)scores) by paper questionnaire. A medical history will document NSAID use, cortisone injections about the shoulder, tobacco usage, narcotic medicine consumption, and pregnancy status. Due to their deleterious effects on healing, all patients will be instructed to not take NSAIDs in the first 6 weeks postoperative. Noncompliance will be noted, but not disqualify the participant from study. Smoking cessation will be strongly encouraged. A shoulder physical examination will be performed; specifically range of motion assessment in multiple planes (frontal flexion, internal and external rotation at 90 degrees of abduction and at side), rotator cuff muscle strength testing with the scapula stabilized, scapula posture observed, and provocative tests for impingement syndrome. Medical records will be reviewed. This evaluation will be performed by the principal investigator and will take 45-60 minutes. The participant will undergo a separate diagnostic ultrasonographic assessment of the rotator cuff tendons by blinded ultrasonographer. This will take 15-30 minutes. Aftercare of each population will be identical and will include a 6-week period of sling immobilization, brief perioperative narcotic medicine, and physical therapy. Physical therapy protocols will be identical. The participants will be treated by a variety of physical therapists. All physical therapy will occur out of the home at a PT clinic. Additional home exercises will be furnished and will be independently performed by the participants. Specifically, at the 2-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, VAS pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder assessed (frontal flexion and external rotation at the side), and the examine will exclude any complications. Physical therapy for shoulder passive range of motion and periscapular strengthening will be prescribed, home exercise sheet provided, and the abduction portion of the sling will be discontinued. Shoulder radiographs will be performed. This visit will take 15-30 minutes. In addition and separate to this,blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. Vascularity using superb microvascular imaging and standard ultrasound techniques will assess vascularity and rotator cuff repair integrity. If possible, elastography will be performed. These images will be stored in de-identified manner within University of Pittsburgh HIPPA-compliant cloud. This will take 15-30 minutes and may be done at a separate time. At the 4-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder (frontal flexion and external rotation at the side) assessed, and the examine will exclude any complications. The prior physical therapy and home exercises will be continued. This visit will take 15-30 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time. At the 6-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder (frontal flexion, internal and external rotation at 90 degrees of abduction and at side) assessed, and the examine will exclude any complications. The sling will be discontinued and new physical therapy and home exercises will be provided; therapy will include shoulder passive range of motion and periscapular strengthening and include rotator cuff strengthening progressing from isometric to concentric then to eccentric with the pace being determined by a physical therapist, but done in a pain free manner. Additionally, patient reported outcomes (UCLA, Rowe, Constant, ASES and SANE scores) will be collected. This visit will take 30-45 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time. At the 3-, 6- and 12-month postoperative visits a history will be obtained to assess shoulder functionality/limitations, quantify NSAID usage, pain score, and assess for any complications. The examination will be similar to the 6-week evaluation, except rotator cuff specific strength will be assessed similar to the preoperative testing. Necessity of ongoing physical therapy will be considered and ordered appropriately. Home exercises will be continued. These visits will take 30-45 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome of Shoulder and Allied Disorders

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    prospective randomized control trial
    Masking
    Investigator
    Masking Description
    Blinded ultrasound assessment
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Rotium patch recipient
    Arm Type
    Experimental
    Arm Description
    Subjects with Rotium nano scaffold patch included in rotator cuff repair construct
    Arm Title
    Control
    Arm Type
    Active Comparator
    Arm Description
    Subjects undergoing non-patch augmented rotator cuff repair
    Intervention Type
    Device
    Intervention Name(s)
    Rotium nanoscaffold
    Intervention Description
    Rotium bioabsorbable nanoscaffold placed between bone-tendon interface of rotator cuff repair construct
    Intervention Type
    Procedure
    Intervention Name(s)
    Control arm rotator cuff repair
    Intervention Description
    Standard rotator cuff repair without Rotium
    Primary Outcome Measure Information:
    Title
    Rotator cuff integrity baseline/preoperative
    Description
    ultrasound assessment of rotator cuff
    Time Frame
    preoperative
    Title
    Rotator cuff repair integrity @ 2 weeks
    Description
    ultrasound assessment of rotator cuff
    Time Frame
    postoperative at 2 weeks
    Title
    Rotator cuff repair integrity @ 4 weeks
    Description
    ultrasound assessment of rotator cuff
    Time Frame
    postoperative at 4 weeks
    Title
    Rotator cuff repair integrity @ 6 weeks
    Description
    ultrasound assessment of rotator cuff
    Time Frame
    postoperative at 6 weeks
    Title
    Rotator cuff repair integrity @ 3 months
    Description
    ultrasound assessment of rotator cuff
    Time Frame
    postoperative 3 months
    Title
    Rotator cuff repair integrity @ 6 months
    Description
    ultrasound assessment of rotator cuff
    Time Frame
    postoperative at 6 months
    Title
    Rotator cuff repair integrity @ 12 months
    Description
    ultrasound assessment of rotator cuff
    Time Frame
    postoperative at 12 months
    Title
    Postoperative rotator cuff vascularity during healing
    Description
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
    Time Frame
    postoperative at 2 weeks
    Title
    Postoperative rotator cuff vascularity during healing
    Description
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
    Time Frame
    postoperative at 4 weeks
    Title
    Postoperative rotator cuff vascularity during healing
    Description
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
    Time Frame
    postoperative at 6 weeks
    Title
    Postoperative rotator cuff vascularity during healing
    Description
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
    Time Frame
    postoperative at 3 months
    Title
    Postoperative rotator cuff vascularity during healing
    Description
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
    Time Frame
    postoperative at 6 months
    Title
    Postoperative rotator cuff vascularity during healing
    Description
    ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
    Time Frame
    postoperative at 12 months
    Secondary Outcome Measure Information:
    Title
    University California Los Angeles Shoulder score
    Description
    Outcome score
    Time Frame
    preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
    Title
    Rowe score
    Description
    Outcome score
    Time Frame
    preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
    Title
    Constant score
    Description
    Outcome score
    Time Frame
    preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
    Title
    American shoulder and elbow surgeons score
    Description
    Outcome score
    Time Frame
    preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
    Title
    SANE score
    Description
    Outcome score
    Time Frame
    preoperative and postoperative at 2,4, 6 weeks and 3,6,12 months postoperative
    Other Pre-specified Outcome Measures:
    Title
    NSAID usage
    Description
    total dosage of NSAIDs
    Time Frame
    postoperative period @ 2,4, 6 weeks and 3, 6, 12 months
    Title
    Cortisone injections about the shoulder
    Description
    Include total number and timeframe relative to surgical date
    Time Frame
    preoperative period
    Title
    Tobacco usage
    Description
    Daily consumption
    Time Frame
    preoperative and postoperative periods @ 2,4, 6 weeks and 3, 6, 12 months
    Title
    Narcotic consumption
    Description
    total dosage of narcotic medicine
    Time Frame
    postoperative period @ 2,4, 6 weeks and 3, 6, 12 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: -symptomatic supraspinatus or supraspinatus and infraspinatus tear that can be repaired to the greater tuberosity in an anatomical manner using a dual layer repair technique. also included will be patients that have concomitant pathology addressed at time of surgery, specifically pathologies of the biceps tendon (tenodesis or tenotomy), arthrosis of the acromioclavicular joint (distal clavicle resection), or labral tearing (debridement or repair) included age range of subjects will be from 18-80 years old Exclusion Criteria: diabetes, cancer or medical states that may impair healing, such as organ transplantation or systemic inflammatory process treated with immune modulating drugs (chemotherapy, immunosuppression drugs) prior surgery to the ipsilateral rotator cuff tendon need of soft tissue releases to accomplish an anatomic repair, partial repairs and/or concomitant subscapularis repair significant glenohumeral arthritis active or ongoing infection pregnancy

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    There is no plan to share data at this time.

    Learn more about this trial

    Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity

    We'll reach out to this number within 24 hrs